Immatics
Sherin Thomas serves as the Associate Director of Quality Control at Immatics, a position held since April 2024. Previously, Sherin held various roles at Marker Therapeutics, Inc. from May 2020 to April 2024, including Quality Control Director, Associate Director, and Manager. Sherin's experience includes a QC Analyst Lead role at Lonza, and a QC Specialist III position at Bellicum Pharmaceuticals, Inc. Prior experience also encompasses work as a Process Development Scientist at Mesoblast Limited and as a Research Associate I at Ensysce Biosciences. Sherin holds a Master's Degree in Biotechnology from the University of Houston-Clear Lake and a Bachelor's Degree in Biotechnology from ICFAI University.
This person is not in the org chart
This person is not in any offices
Immatics
9 followers
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.